WELCOME TO

ExpreS2ion Biotech

INVESTOR SITE

Financial Calendar

Latest press releases

Pareto and Analysguiden publish research reports with SEK 25 per share price targets and ExpreS2ion publishes third quarter financial report video presentation

Non-regulatory pressrelease

Hørsholm, Denmark, November 18, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Pareto Securities and Analysguiden have both published research reports on ExpreS2ion in November. Pareto reiterated its SEK 25 price target while Analysguiden reduced its price target to SEK 25 per share from SEK 30 per share. Furthermore, a…

Read more

ExpreS2ion announces financial results for the third quarter 2022

Regulatory pressrelease

Hørsholm, Denmark, November 17, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its third quarter financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.

Read more

View all